摘要
对40例糖尿病性骨质疏松症(DOP)患者进行强骨宝颗粒剂用药前后腰椎骨密度(BMD)、空腹血糖(FBG)、血清果糖胺(FSM)及有关骨代谢的血尿生化指标变化的检测 ,结果显示强骨宝用药20W后 ,患者BMD提高了1 849 % ,FBG、FSM显著下降(P<0 05 ,P<0 01) ,BGP、S -Mg非常显著升高(P<0 01) ,尿钙、尿磷、尿羟脯氨酸排泄量显著减少(P<0 05)。揭示强骨宝可以提高DOP患者的BMD ,并且可能是通过降血糖、促进骨形成。
Test the bone density of lumbar vertebreae(BMD),fasting blood glucose(FBG),serum fructose amine(FSM)and the hematuria biochemical quota about bone metabolism for 40 cases of DOP patients before and after taking Qianggubao granule.The results showed that after taking the medicine for 20w,patiens' BMD rose by 1 849%,FBG and FSM marked decreasedhy(P<0 01,P<0 01),the excretion of urine C,P and Hyp obviously decreased(P<0 05). It indicated that Qianggubao could increase DOP patients BMD which might be functioned by lowering blood gulcose,promoting bone formation and inhibiting bone absorption.
出处
《浙江中医学院学报》
2002年第4期15-17,共3页
Journal of Zhejiang College of Traditional Chinese Medicine
基金
福建省自然科学基金资助(编号 :C9810036)
